NCT00089843View on ClinicalTrials.gov

Bone Loss in Women With Anorexia Nervosa

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Anorexia Nervosa
Interventions
DRUG

Testosterone

Testosterone patch 150mcg daily

DRUG

Actonel (risedronate)

Actonel (risedronate) 35mg PO one time weekly

DRUG

Placebo Actonel (risedronate)

Placebo tablet identical in appearance to active Actonel (risedronate) tablet

DRUG

Placebo testosterone

Placebo patch identical in appearance to testosterone patch

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00089843 - Bone Loss in Women With Anorexia Nervosa | Biotech Hunter | Biotech Hunter